Back to Woodline Partners LP Woodline Partners LP

ALLOALLO
Showing 8 of 25 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in ALLOGENE THERAPEUTICS INC

Woodline Partners LP holds 4.5M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $9.4M as of 2026-Q2. The position was increased (+28.6% shares). ALLO represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$9.4M

Current Shares

4.5M

Total Value Change

-$2.9M

Total Shares Change

+136,324

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+28.6%
$9.4M0.0%$2.08
35
2026-Q1
Increased
3.5M
+0.0%
$8.5M0.0%$2.53
27
2025-Q4
Decreased
3.5M
-19.7%
$4.8M0.0%$1.31
0
2025-Q3
Unchanged
4.4M
0.0%
$5.4M0.0%$1.27
0
2025-Q2
Unchanged
4.4M
0.0%
$4.9M0.0%$1.18
0
2025-Q1
Increased
4.4M
+0.0%
$6.4M0.0%$1.55
27
2024-Q4
Decreased
4.4M
-0.1%
$9.3M0.1%$2.10
0
2024-Q3
Increased
4.4M
+0.1%
$12.2M0.1%$2.91
33

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used